Abstract
Nephrolithiasis is a common urological disease accompanied by high morbidity worldwide. Evidences indicate that high-level CaOx crystals in the body can lead to renal tubular epithelial cell (RTEC) injury and RTEC injury is a critical precipitating factor for the formation of kidney stones. FGF21 has recently been revealed as the considerable marker in various kidney dysfunction and exerts the nephroprotective effects in various kidney diseases. This current study was formulated to fully elucidate the biological role of FGF21 in nephrolithiasis and probe into the intrinsic mechanisms underlying the protective effects of FGF21 against RTEC injury. In this work, HK-2 cells were incubated with 100 mg/ml COM for 24 h to establish in vitro RTEC injury model. COM-treated HK-2 cells were transfected with Oe-FGF21 to perform gain-of-function experiments. For rescue experiments, HK-2 cells were pretreated with 10 μM Nrf2 inhibitor ML385 for 24 h to thoroughly discuss the role of Nrf2 signaling in FGF21-mediating nephroprotective effects. It was verified that overexpression of FGF21 relieved COM-induced proliferation inhibition, cell injury, apoptosis, oxidative damage and ferroptosis of RTECs. ML385 treatment partially abolished the protective effects of FGF21 against COM injury in RTECs. In conclusion, up-regulation of FGF21 can relieve COM-induced proliferation inhibition, cell injury, apoptosis, oxidative damage and ferroptosis of RTECs through activating Nrf2 signaling pathway.
Similar content being viewed by others
Data availability
The datasets analyzed during the current study are available from the corresponding author on reasonable request.
References
Abais-Battad JM, Alsheikh AJ, Pan X et al (2019) Dietary effects on dahl salt-sensitive hypertension, renal damage, and the t lymphocyte transcriptome. Hypertension 74:854–863. https://doi.org/10.1161/HYPERTENSIONAHA.119.12927
Cheng Y, Zhang J, Guo W et al (2016) Up-regulation of Nrf2 is involved in FGF21-mediated fenofibrate protection against type 1 diabetic nephropathy. Free Radic Biol Med 93:94–109. https://doi.org/10.1016/j.freeradbiomed.2016.02.002
Chung HJ (2014) The role of Randall plaques on kidney stone formation. Transl Androl Urol 3:251–254. https://doi.org/10.3978/j.issn.2223-4683.2014.07.03
D’Costa MR, Haley WE, Mara KC et al (2019) Symptomatic and radiographic manifestations of kidney stone recurrence and their prediction by risk factors: a prospective cohort study. J Am Soc Nephrol 30:1251–1260. https://doi.org/10.1681/ASN.2018121241
Dong C, Song C, He Z et al (2023) Protective efficacy of Schizandrin B on ameliorating nephrolithiasis via regulating GSK3beta/Nrf2 signaling-mediated ferroptosis in vivo and in vitro. Int Immunopharmacol 117:110042. https://doi.org/10.1016/j.intimp.2023.110042
Feng Q, Yang Y, Qiao Y et al (2023) Quercetin ameliorates diabetic kidney injury by inhibiting ferroptosis via activating nrf2/ho-1 signaling pathway. Am J Chin Med 51:997–1018. https://doi.org/10.1142/S0192415X23500465
He Z, Liao W, Song Q et al (2021) Role of ferroptosis induced by a high concentration of calcium oxalate in the formation and development of urolithiasis. Int J Mol Med 47:289–301. https://doi.org/10.3892/ijmm.2020.4770
Hindricks J, Ebert T, Bachmann A et al (2014) Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction. Clin Endocrinol (oxf) 80:918–924. https://doi.org/10.1111/cen.12380
Hirose M, Yasui T, Okada A et al (2010) Renal tubular epithelial cell injury and oxidative stress induce calcium oxalate crystal formation in mouse kidney. Int J Urol 17:83–92. https://doi.org/10.1111/j.1442-2042.2009.02410.x
Hu J, Gu W, Ma N, Fan X, Ci X (2022) Leonurine alleviates ferroptosis in cisplatin-induced acute kidney injury by activating the Nrf2 signalling pathway. Br J Pharmacol 179:3991–4009. https://doi.org/10.1111/bph.15834
Jia Z, Li W, Bian P et al (2021) Ursolic acid treats renal tubular epithelial cell damage induced by calcium oxalate monohydrate via inhibiting oxidative stress and inflammation. Bioengineered 12:5450–5461. https://doi.org/10.1080/21655979.2021.1955176
Kirkali Z, Rasooly R, Star RA, Rodgers GP (2015) Urinary stone disease: progress, status, and needs. Urology 86:651–653. https://doi.org/10.1016/j.urology.2015.07.006
Li F, Liu Z, Tang C, Cai J, Dong Z (2018) FGF21 is induced in cisplatin nephrotoxicity to protect against kidney tubular cell injury. FASEB J 32:3423–3433. https://doi.org/10.1096/fj.201701316R
Li Y, Zhang J, Liu H et al (2019) Curcumin ameliorates glyoxylate-induced calcium oxalate deposition and renal injuries in mice. Phytomedicine 61:152861. https://doi.org/10.1016/j.phymed.2019.152861
Li J, Cao F, Yin HL et al (2020) Ferroptosis: past, present and future. Cell Death Dis 11:88. https://doi.org/10.1038/s41419-020-2298-2
Li Z, Chang L, Ren X, Hu Y, Chen Z (2021) Modulation of rat kidney stone crystallization and the relative oxidative stress pathway by green tea polyphenol. ACS Omega 6:1725–1731. https://doi.org/10.1021/acsomega.0c05903
Lin Z, Zhou Z, Liu Y et al (2011) Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese. PLoS ONE 6:e18398. https://doi.org/10.1371/journal.pone.0018398
Lu H, Sun X, Jia M et al (2021) Rosiglitazone suppresses renal crystal deposition by ameliorating tubular injury resulted from oxidative stress and inflammatory response via promoting the nrf2/ho-1 pathway and shifting macrophage polarization. Oxid Med Cell Longev 2021:5527137. https://doi.org/10.1155/2021/5527137
Miess H, Dankworth B, Gouw AM et al (2018) The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma. Oncogene 37:5435–5450. https://doi.org/10.1038/s41388-018-0315-z
Qiongyue Z, Xin Y, Meng P et al (2022) Post-treatment with irisin attenuates acute kidney injury in sepsis mice through anti-ferroptosis via the sirt1/nrf2 pathway. Front Pharmacol 13:857067. https://doi.org/10.3389/fphar.2022.857067
Rodgers AL (2017) Physicochemical mechanisms of stone formation. Urolithiasis 45:27–32. https://doi.org/10.1007/s00240-016-0942-1
Shao M, Yu L, Zhang F et al (2015) Additive protection by LDR and FGF21 treatment against diabetic nephropathy in type 2 diabetes model. Am J Physiol Endocrinol Metab 309:E45-54. https://doi.org/10.1152/ajpendo.00026.2015
Shi YC, Lu WW, Hou YL et al (2018) Protection effect of exogenous fibroblast growth factor 21 on the kidney injury in vascular calcification rats. Chin Med J (england) 131:532–538. https://doi.org/10.4103/0366-6999.226065
Singh P, Harris PC, Sas DJ, Lieske JC (2022) The genetics of kidney stone disease and nephrocalcinosis. Nat Rev Nephrol 18:224–240. https://doi.org/10.1038/s41581-021-00513-4
Tang S, Xiao X (2020) Ferroptosis and kidney diseases. Int Urol Nephrol 52:497–503. https://doi.org/10.1007/s11255-019-02335-7
Tian H, Liang Q, Shi Z, Zhao H (2023) Hyperoside ameliorates renal tubular oxidative damage and calcium oxalate deposition in rats through ampk/nrf2 signaling axis. J Renin Angiotensin Aldosterone Syst 2023:5445548. https://doi.org/10.1155/2023/5445548
Tsujihata M (2008) Mechanism of calcium oxalate renal stone formation and renal tubular cell injury. Int J Urol 15:115–120. https://doi.org/10.1111/j.1442-2042.2007.01953.x
Wang X, Chen X, Zhou W et al (2022) Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways. Acta Pharm Sin B 12:708–722. https://doi.org/10.1016/j.apsb.2021.10.005
Weng HC, Lu XY, Xu YP et al (2021) Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism. Mol Med 27:147. https://doi.org/10.1186/s10020-021-00408-x
Woo YC, Xu A, Wang Y, Lam KS (2013) Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives. Clin Endocrinol (oxford) 78:489–496. https://doi.org/10.1111/cen.12095
Wu A, Feng B, Yu J et al (2021) Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis. Redox Biol 46:102131. https://doi.org/10.1016/j.redox.2021.102131
Xie J, Ye Z, Li L et al (2022) Ferrostatin-1 alleviates oxalate-induced renal tubular epithelial cell injury, fibrosis and calcium oxalate stone formation by inhibiting ferroptosis. Mol Med Rep. https://doi.org/10.3892/mmr.2022.12772
Yang Y, Hong S, Lu Y et al (2022) CAV1 alleviated CaOx stones formation via suppressing autophagy-dependent ferroptosis. PeerJ 10:e14033. https://doi.org/10.7717/peerj.14033
Yu Y, He J, Li S et al (2016) Fibroblast growth factor 21 (FGF21) inhibits macrophage-mediated inflammation by activating Nrf2 and suppressing the NF-kappaB signaling pathway. Int Immunopharmacol 38:144–152. https://doi.org/10.1016/j.intimp.2016.05.026
Yu Z, Lin L, Jiang Y et al (2019) Recombinant fgf21 protects against blood-brain barrier leakage through nrf2 upregulation in type 2 diabetes mice. Mol Neurobiol 56:2314–2327. https://doi.org/10.1007/s12035-018-1234-2
Zhou C, Wu M, Liu G, Zhou L (2023) HP1 induces ferroptosis of renal tubular epithelial cells through NRF2 pathway in diabetic nephropathy. Open Life Sci 18:20220678. https://doi.org/10.1515/biol-2022-0678
Acknowledgements
Not applicable.
Funding
This research was funded by Hangzhou Medical Health Science and Technology Project (B20200515) and Hangzhou Biomedicine and Health Industry Development Support Science and Technology Project (2023WJC001).
Author information
Authors and Affiliations
Contributions
Jie Zhang, Guanding Zhang and Chao Chen contributed to the concept and designed the study. Jie Zhang, Guanding Zhang, Lijun Jiang, Danyang Qiu and Guoping Wang performed the experiments. Jie Zhang and Guanding Zhang contributed to the data collection and analysis. Jie Zhang, Guanding Zhang and Chao Chen wrote the manuscript. Chao Chen critically revised the manuscript. All authors read and approved the final manuscript and can confirm the authenticity of all the raw data.
Corresponding author
Ethics declarations
Conflict of interest
No potential conflict of interest was reported by the authors.
Ethics approval and consent to participate
Not applicable.
Patient consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, J., Zhang, G., Jiang, L. et al. FGF21 relieves calcium oxalate-induced cell injury, apoptosis, oxidative damage and ferroptosis of renal tubular epithelial cells through activating Nrf2 signaling pathway. Cytotechnology (2024). https://doi.org/10.1007/s10616-024-00633-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10616-024-00633-2